7.2.3  Notific ation  7.2.3.1  If the review of an Adverse Analytical  Finding under Article 7.2.2  of these Rules  does not reveal an applicable TUE or entitlement to a TUE as provided  in the International Standard  for Therapeutic Use Exemptions , an apparent  departure from the International Standard  for Testing and Investigations or the International Standard for Laboratories that  caused the Adverse Analytical Finding  or that it is apparent that the Adverse Analytical Finding was caused by an ingestion of the relevant Prohibited Substance  through a permitted route , the ITA  shall promptly notify:   (a) the Athlete;   (b) the Athlete’s NOC ;  (c) the Athlete’s International Federation (who will be entitled to  send a representative(s) to attend the hearing);   (d) the relevant National Anti -Doping Organisation of the Athlete ;  (e) the IOC; and  (f) WADA (which will be entitled to send a representative to attend the  hearing) and, during the Period of the Olympic Games Paris 2024 , a representative of the Independent Observer Program me  of the existence of the Adverse Analytical Finding , and the essential  details available concerning the case  as further set out in Article 7.2.